Sophonix Co., Ltd

The company has a complete product portfolio of independent intellectual property rights, including: automatic chemiluminescence immunoassay analyzers (CLEIA method), pathological diagnosis system (Automatic Immunohistochemical Staining Machine) and molecular diagnosis system (Isothermal Nucleic Acid Amplification Analyzer, LAMP technology) and a broad panel of the compatible tests, which are suitable for POCT rapid detection sites.